Lilly (LLY), Boehringer Reports Significant Data from LY2605541 Phase 2 on Type 2 Diabetes

Go back to Lilly (LLY), Boehringer Reports Significant Data from LY2605541 Phase 2 on Type 2 Diabetes
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1255.40 +11.00 (0.88%)
Previous Close $1244.40    52 Week High $88.16 
Open $1232.00    52 Week Low $67.88 
Day High $1271.22    P/E 290.60 
Day Low $1230.00    EPS $4.32 
Volume 2,505,585